Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000054.xml
Pharmacopsychiatry 2022; 55(05): 274-275
DOI: 10.1055/a-1882-6802
DOI: 10.1055/a-1882-6802
Letter to the Editor
The Therapeutic Potential of Pimavanserin in the Treatment of Hallucinogen Induced Psychosis and Persistent Perceptual Symptoms
Publication History
Article published online:
11 July 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Cusick E, Gupta V. Pimavanserin. In: StatPearls. Treasure Island (FL). 2022
- 2 Howland RH. Pimavanserin: An Inverse Agonist Antipsychotic Drug. J Psychosoc Nurs Ment Health Serv 2016; 54: 21-24 DOI: 10.3928/02793695-20160523-01.
- 3 Jalal B. The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug. Psychopharmacology (Berl) 2018; 235: 3083-3091 DOI: 10.1007/s00213-018-5042-1.
- 4 Litjens RP, Brunt TM, Alderliefste GJ. et al. Hallucinogen persisting perception disorder and the serotonergic system: a comprehensive review including new MDMA-related clinical cases. Eur Neuropsychopharmacol 2014; 24: 1309-1323 DOI: 10.1016/j.euroneuro.2014.05.008.
- 5 American Psychiatric A.. Diagnostic and Statistical Manual of Mental Disorders 2013; DOI: 10.1176/appi.books.9780890425596.
- 6 Martinotti G, Santacroce R, Pettorruso M. et al. Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. Brain Sci 2018; 8 DOI: 10.3390/brainsci8030047.
- 7 Alcantara AG. Is there a role for the alpha2 antagonism in the exacerbation of hallucinogen-persisting perception disorder with risperidone?. J Clin Psychopharmacol 1998; 18: 487-488 DOI: 10.1097/00004714-199812000-00016.
- 8 Lev-Ran S, Feingold D, Frenkel A. et al. Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigation. J Dual Diagn 2014; 10: 79-83 DOI: 10.1080/15504263.2014.906155.
- 9 Lev-Ran S, Feingold D, Rudinski D. et al. Schizophrenia and hallucinogen persisting perception disorder: A clinical investigation. Am J Addict 2015; 24: 197-199 DOI: 10.1111/ajad.12204.
- 10 Nutting S, Bruinsma T, Anderson M. et al. Psychotic and Still Tripping – Hallucinogen Persisting Perception Disorder and First Break Psychosis in an Adolescent. Int J Ment Health Addict 2020; 19: 2440-2442 DOI: 10.1007/s11469-020-00338-5.